Geministatins: new depside antibiotics from the fungus Austroacremonium gemini

Andrew Crombie,John A. Kalaitzis,Rachel Chen,Daniel Vuong,Alastair E. Lacey,Ernest Lacey,Roger G. Shivas,Yu Pei Tan,Nicolau Sbaraini,Yit-Heng Chooi,Andrew M. Piggott
DOI: https://doi.org/10.1038/s41429-024-00755-x
2024-06-27
The Journal of Antibiotics
Abstract:Two new depside antibiotics, geministatins A ( 1 ) and B ( 2 ), were isolated from the fungus Austroacremonium gemini MST-FP2131 ( Sordariomycetes , Ascomycota ), which was recovered from rotting wood in the wet tropics of northern Australia. The structures of the geministatins were elucidated by detailed spectroscopic analysis, chemical degradation and comparison with literature values. Chemical degradation of 1 and 2 yielded three new analogues, geministatins C–E ( 3 – 5 ), as well as a previously reported compound dehydromerulinic acid A ( 6 ). Compounds 1 , 2 and 6 exhibited antibacterial activity against the Gram-positive bacteria Bacillus subtilis (MIC 0.2–1.6 μg mL −1 ) and Staphylococcus aureus (MIC 0.78–6.3 μg mL −1 ), including methicillin-resistant S. aureus (MRSA), while 4 exhibited antifungal activity against the yeast Saccharomyces cerevisiae (MIC 13 μg mL −1 ).
pharmacology & pharmacy,immunology,biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?